April 24, 2024 - MTRAF
Buried deep in Metro Inc.'s recent Q1 2024 earnings call lies a tantalizing clue about the future of their pharmacy division – a clue most analysts seem to have missed. While the call focuses heavily on the transition to the new Terrebonne automated distribution center, it also casually mentions a significant public sector strike in Quebec that impacted the quarter. Teachers, and later other public sector workers, walked off the job for several weeks, significantly impacting disposable income in November and December.
While this strike undoubtedly created a headwind for seasonal sales, as François Thibault, Executive VP and CFO, acknowledges, could this temporary setback actually pave the way for explosive pharmacy growth in the coming quarters?
Here's why this strike, combined with other data points from the call, paints a compelling picture of Jean Coutu's untapped potential.
First, consider the impact of the strike on front-end sales in Q1. While overall pharmacy same-store sales were up a respectable 3.9%, commercial sales (excluding prescriptions) were down 1.2%. The primary culprit? A decline in over-the-counter (OTC) medication sales compared to last year's exceptionally high demand for cough and cold products. However, the strike likely compounded this decline by squeezing disposable income and dampening consumer spending on non-essential front-end items.
Now, let's fast forward to the second quarter. Eric La Flèche, President and CEO, notes that the cough and cold season, which started late in Q1, is now "permanently in place." This suggests a potential surge in OTC demand, driving increased pharmacy traffic.
However, the real kicker comes from François Thibault's comment that Q2 is showing "better trends" in front-end sales, even as they lap last year's high comps. This implies that, despite facing a challenging year-over-year comparison, Jean Coutu's front-end sales are demonstrating robust growth in the current quarter.
Here's where the strike comes back into play. With the strike behind them, Quebec's public sector workers are now enjoying a return to normal disposable income. Combine this with increased pharmacy traffic fueled by the cough and cold season, and you have a recipe for a potential front-end sales explosion.
But the story doesn't end there. Metro Inc. also boasts a potent loyalty program in Moi, which has already surpassed 2.5 million active members – double the size of its predecessor, Metro&Moi. Importantly, the Q1 2024 earnings call highlights the program's success in driving cross-shopping behavior between banners, with potential for further expansion. This suggests that increased pharmacy traffic, fueled by the factors discussed above, could spill over into Metro's grocery banners, creating a virtuous cycle of growth across their entire retail ecosystem.
While the exact magnitude of this potential growth remains to be seen, the numbers offer a compelling glimpse into the possibilities. Assuming a conservative 5% lift in Jean Coutu's front-end sales due to the combined impact of the strike's end and increased OTC demand, we're looking at a potential $25 million increase in quarterly revenue. Factor in additional cross-shopping benefits to their grocery banners, and the upside could be even more significant.
To visualize the potential impact of the strike and the cough and cold season, let's compare the front-end sales trends from Q1 and Q2. Keep in mind that these are hypothetical figures based on the information from the earnings calls and are meant to illustrate the potential trend shift.
This is not mere speculation. Remember, the Q2 2024 earnings call explicitly states that Q2 is already showing "better trends" in front-end sales. It's plausible that the strike's end is already contributing to this momentum, a trend that could further accelerate as the cough and cold season reaches its peak.
Metro Inc.'s management has consistently demonstrated their ability to navigate complex market dynamics and deliver consistent growth. This strategic blend of a powerful loyalty program, a robust pharmacy network, and shrewd navigation of external factors like the strike suggests that Jean Coutu is poised to unlock a new era of growth. While the market fixates on Terrebonne's automation, Metro Inc. might be quietly building a pharmacy powerhouse, driven by a secret weapon few have noticed: a teacher's strike.
Metric | Q1 2024 | Source |
---|---|---|
Overall Pharmacy Same-Store Sales Growth | 3.9% | Q1 2024 Earnings Call |
Commercial Sales (Excluding Prescriptions) Growth | -1.2% | Q1 2024 Earnings Call |
Moi Active Members | 2.5 million+ | Q1 2024 Earnings Call |
"Fun Fact: Jean Coutu, the founder of the Jean Coutu pharmacy chain, was originally a teacher before entering the pharmaceutical industry. This unique background might explain the company's unforeseen potential growth stemming from a teacher's strike – a connection that would be hard to make without knowing this fun fact."